Taysha Gene Therapies, Inc. (TSHA) Stock Chart - Revenue & Earnings | Quarter Chart
Income Statement▲
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Cash Flow Statement▲
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Balance Sheet▲
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Key Metrics▼
Taysha Gene Therapies, Inc. (TSHA) quarterly earnings & revenue
Taysha Gene Therapies, Inc. (TSHA) is a publicly traded company, operating in the Biotechnology industry.
Taysha Gene Therapies, Inc. (TSHA) has a dedicated financial chart page covering quarterly revenue, earnings, cash flow, balance-sheet metrics, and valuation ratios. Sign in to check the company access available with your account.
Taysha Gene Therapies, Inc. (TSHA) — frequently asked questions
What financial charts are available for Taysha Gene Therapies, Inc. (TSHA)?
The Taysha Gene Therapies, Inc. chart page covers quarterly revenue, earnings, cash flow, balance-sheet metrics, and valuation ratios.
How can I view TSHA's quarterly financial history?
Sign in to check your company allowance or compare Quarter Chart plans for access.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)